Ethical analysis to improve decision-making on health technologies
Standard
Ethical analysis to improve decision-making on health technologies. / Saarni, Samuli I; Hofmann, Bjørn; Lampe, Kristian; Lühmann, Dagmar; Mäkelä, Marjukka; Velasco-Garrido, Marcial; Autti-Rämö, Ilona.
In: B WORLD HEALTH ORGAN, Vol. 86, No. 8, 08.2008, p. 617-23.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Ethical analysis to improve decision-making on health technologies
AU - Saarni, Samuli I
AU - Hofmann, Bjørn
AU - Lampe, Kristian
AU - Lühmann, Dagmar
AU - Mäkelä, Marjukka
AU - Velasco-Garrido, Marcial
AU - Autti-Rämö, Ilona
PY - 2008/8
Y1 - 2008/8
N2 - Health technology assessment (HTA) is the multidisciplinary study of the implications of the development, diffusion and use of health technologies. It supports health-policy decisions by providing a joint knowledge base for decision-makers. To increase its policy relevance, HTA tries to extend beyond effectiveness and costs to also considering the social, organizational and ethical implications of technologies. However, a commonly accepted method for analysing the ethical aspects of health technologies is lacking. This paper describes a model for ethical analysis of health technology that is easy and flexible to use in different organizational settings and cultures. The model is part of the EUnetHTA project, which focuses on the transferability of HTAs between countries. The EUnetHTA ethics model is based on the insight that the whole HTA process is value laden. It is not sufficient to only analyse the ethical consequences of a technology, but also the ethical issues of the whole HTA process must be considered. Selection of assessment topics, methods and outcomes is essentially a value-laden decision. Health technologies may challenge moral or cultural values and beliefs, and their implementation may also have significant impact on people other than the patient. These are essential considerations for health policy. The ethics model is structured around key ethical questions rather than philosophical theories, to be applicable to different cultures and usable by non-philosophers. Integrating ethical considerations into HTA can improve the relevance of technology assessments for health care and health policy in both developed and developing countries.
AB - Health technology assessment (HTA) is the multidisciplinary study of the implications of the development, diffusion and use of health technologies. It supports health-policy decisions by providing a joint knowledge base for decision-makers. To increase its policy relevance, HTA tries to extend beyond effectiveness and costs to also considering the social, organizational and ethical implications of technologies. However, a commonly accepted method for analysing the ethical aspects of health technologies is lacking. This paper describes a model for ethical analysis of health technology that is easy and flexible to use in different organizational settings and cultures. The model is part of the EUnetHTA project, which focuses on the transferability of HTAs between countries. The EUnetHTA ethics model is based on the insight that the whole HTA process is value laden. It is not sufficient to only analyse the ethical consequences of a technology, but also the ethical issues of the whole HTA process must be considered. Selection of assessment topics, methods and outcomes is essentially a value-laden decision. Health technologies may challenge moral or cultural values and beliefs, and their implementation may also have significant impact on people other than the patient. These are essential considerations for health policy. The ethics model is structured around key ethical questions rather than philosophical theories, to be applicable to different cultures and usable by non-philosophers. Integrating ethical considerations into HTA can improve the relevance of technology assessments for health care and health policy in both developed and developing countries.
KW - Attitude to Health
KW - Cost-Benefit Analysis
KW - Culture
KW - Decision Making, Organizational
KW - Diffusion of Innovation
KW - Ethical Analysis
KW - Health Policy
KW - Humans
KW - Interdisciplinary Communication
KW - Internationality
KW - Models, Organizational
KW - Morals
KW - Pilot Projects
KW - Program Evaluation
KW - Social Responsibility
KW - Social Values
KW - Technology Assessment, Biomedical
M3 - SCORING: Journal article
C2 - 18797620
VL - 86
SP - 617
EP - 623
JO - B WORLD HEALTH ORGAN
JF - B WORLD HEALTH ORGAN
SN - 0042-9686
IS - 8
ER -